|
1
|
Intestinal villous M cells: an antigen entry site in the mucosal epithelium.
|
Proc Natl Acad Sci U S A
|
2004
|
2.75
|
|
2
|
Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection.
|
J Clin Invest
|
2013
|
2.15
|
|
3
|
Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis.
|
Proc Natl Acad Sci U S A
|
2010
|
1.67
|
|
4
|
Comprehensive gene expression profiling of Peyer's patch M cells, villous M-like cells, and intestinal epithelial cells.
|
J Immunol
|
2008
|
1.58
|
|
5
|
Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination.
|
Proc Natl Acad Sci U S A
|
2007
|
1.51
|
|
6
|
A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses.
|
J Exp Med
|
2007
|
1.47
|
|
7
|
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines.
|
Nat Mater
|
2010
|
1.45
|
|
8
|
Specific expression of apolipoprotein A-IV in the follicle-associated epithelium of the small intestine.
|
Dig Dis Sci
|
2014
|
1.38
|
|
9
|
A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses.
|
Proc Natl Acad Sci U S A
|
2005
|
1.24
|
|
10
|
Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.
|
Proc Natl Acad Sci U S A
|
2010
|
1.11
|
|
11
|
Novel vaccine development strategies for inducing mucosal immunity.
|
Expert Rev Vaccines
|
2012
|
1.04
|
|
12
|
Distinct fucosylation of M cells and epithelial cells by Fut1 and Fut2, respectively, in response to intestinal environmental stress.
|
Biochem Biophys Res Commun
|
2010
|
0.97
|
|
13
|
Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit.
|
J Immunol
|
2003
|
0.96
|
|
14
|
Antigen-sampling cells in the salmonid intestinal epithelium.
|
Dev Comp Immunol
|
2010
|
0.94
|
|
15
|
New horizon of mucosal immunity and vaccines.
|
Curr Opin Immunol
|
2009
|
0.93
|
|
16
|
A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
|
J Immunol
|
2009
|
0.91
|
|
17
|
Nasal vaccination with the 40-kilodalton outer membrane protein of Porphyromonas gingivalis and a nontoxic chimeric enterotoxin adjuvant induces long-term protective immunity with reduced levels of immunoglobulin E antibodies.
|
Infect Immun
|
2008
|
0.88
|
|
18
|
Biological role of Ep-CAM in the physical interaction between epithelial cells and lymphocytes in intestinal epithelium.
|
Clin Immunol
|
2004
|
0.88
|
|
19
|
Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.
|
Infect Immun
|
2013
|
0.87
|
|
20
|
Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation.
|
Infect Immun
|
2005
|
0.86
|
|
21
|
Identification of low-abundance proteins of bovine colostral and mature milk using two-dimensional electrophoresis followed by microsequencing and mass spectrometry.
|
Electrophoresis
|
2002
|
0.83
|
|
22
|
RNAi-mediated suppression of endogenous storage proteins leads to a change in localization of overexpressed cholera toxin B-subunit and the allergen protein RAG2 in rice seeds.
|
Plant Cell Rep
|
2013
|
0.80
|
|
23
|
Non-toxic Stx derivatives from Escherichia coli possess adjuvant activity for mucosal immunity.
|
Vaccine
|
2004
|
0.80
|
|
24
|
MucoRice-cholera toxin B-subunit, a rice-based oral cholera vaccine, down-regulates the expression of α-amylase/trypsin inhibitor-like protein family as major rice allergens.
|
J Proteome Res
|
2013
|
0.79
|
|
25
|
Novel transgenic rice-based vaccines.
|
Arch Immunol Ther Exp (Warsz)
|
2014
|
0.78
|
|
26
|
A soluble nonglycosylated recombinant infectious hematopoietic necrosis virus (IHNV) G-protein induces IFNs in rainbow trout (Oncorhynchus mykiss).
|
Fish Shellfish Immunol
|
2008
|
0.78
|
|
27
|
Innate immunomodulation with recombinant interferon-alpha enhances resistance of rainbow trout (Oncorhynchus mykiss) to infectious hematopoietic necrosis virus.
|
Dev Comp Immunol
|
2008
|
0.78
|
|
28
|
Potential roles of CCR5(+) CCR6(+) dendritic cells induced by nasal ovalbumin plus Flt3 ligand expressing adenovirus for mucosal IgA responses.
|
PLoS One
|
2013
|
0.77
|
|
29
|
Biological characterisation of a recombinant Atlantic salmon type I interferon synthesized in Escherichia coli.
|
Fish Shellfish Immunol
|
2007
|
0.77
|
|
30
|
Enhanced survival of shrimp, Penaeus (Marsupenaeus) japonicus from white spot syndrome disease after oral administration of recombinant VP28 expressed in Brevibacillus brevis.
|
Fish Shellfish Immunol
|
2008
|
0.75
|
|
31
|
[Current progress in the development of mucosal vaccines].
|
Nihon Rinsho
|
2011
|
0.75
|
|
32
|
[M cells: development and function].
|
Tanpakushitsu Kakusan Koso
|
2002
|
0.75
|
|
33
|
ISH NIA OS-02 ATTENUATION OF HYPERTENSION BY LESS-INVASIVE INTRANASAL VACCINATION AGAINST ANGIOTENSIN II TYPE 1 RECEPTOR IN SPONTANEOUSLY HYPERTENSIVE RATS.
|
J Hypertens
|
2016
|
0.75
|
|
34
|
ISH NIA OS-02 ATTENUATION OF HYPERTENSION BY LESS-INVASIVE INTRANASAL VACCINATION AGAINST ANGIOTENSIN II TYPE 1 RECEPTOR IN SPONTANEOUSLY HYPERTENSIVE RATS.
|
J Hypertens
|
2016
|
0.75
|
|
35
|
Intranasal vaccination against angiotensin II type 1 receptor and pneumococcal surface protein A attenuates hypertension and pneumococcal infection in rodents.
|
J Hypertens
|
2017
|
0.75
|